Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Despite New Spin, Obesity and Diabetes Drug Failed Alzheimer’s Trial
An Unexpected Way to Lower Your Dementia Risk: Pet Ownership
What Happens When Insurance Refuses to Cover Your Alzheimer’s Prescription?
AAIC: Experts Discuss the Future of Alzheimer’s Treatments
Updates on Alzheimer’s Drug Research from AAIC 2024
AAIC: Optimism for Alzheimer’s Blood Tests
EU Regulators Reject Alzheimer’s Drug Leqembi
TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.02)
Drinking and Brain Health: Is There a ‘Healthy’ Amount of Alcohol?
How Do You Explain Dementia to a Child? 6 Things to Try
STUDY: In Menopause, Estrogen Drops — Here’s How the Brain Reacts
Considering Enrolling in a Dementia Clinical Trial? 6 Things You Should Know
How Do Alzheimer’s Clinical Trials Work? And Other FAQs
FDA Approves New Alzheimer’s Drug Kisunla (Donanemab)
Why the ADDF Is Betting $5M on This Experimental Alzheimer’s Drug
Previous
11
12
13
Next
Page load link
Go to Top